Wednesday, July 8, 2026

Drug profile · INN

albumin human

albumin human (OPTISON) is a bilirubin sequestering agent. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 2
Pipeline programs 1
News articles 0
Drug details — albumin human
US status
approved
Class
Route
INJECTION
Patents
2
Programs
1
Data quality
0.84

Quick answer

albumin human (OPTISON) is a bilirubin sequestering agent. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN albumin human
Brand OPTISON
Mechanism Bilirubin sequestering agent
Target Bilirubin
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Bilirubin sequestering agent

Primary target: Bilirubin

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Albumin Human Unknown · United Therapeutics Europe · Burn Injury

Related patents

  1. US 8993519

    Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 8323634

    Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is albumin human?

albumin human (OPTISON) is a bilirubin sequestering agent. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for albumin human?

OPTISON is a marketed brand name for albumin human. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of albumin human?

albumin human has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.